Home > Healthcare > Medical Devices > Medical Supplies > Ophthalmic Sutures Market

Ophthalmic Sutures Market Analysis

  • Report ID: GMI3358
  • Published Date: Oct 2024
  • Report Format: PDF

Ophthalmic Sutures Market Analysis

By type, the market is categorized into natural and synthetic. The synthetic segment dominated the market with a revenue of USD 620.5 million in 2023.
 

  • Synthetic sutures are manufactured under controlled conditions, ensuring uniformity and reliability in their performance. This consistency is crucial for delicate ophthalmic procedures, where precision and reliability are paramount.
     
  • Moreover, synthetic materials such as polypropylene, nylon, and polyglycolic acid offer superior tensile strength, elasticity, and biocompatibility compared to natural sutures. These properties help maintain wound integrity and support healing in sensitive eye tissues, increasing their demand in the market.
     

By material, the ophthalmic sutures market is categorized into PGA, nylon, silk, polypropylene, and other materials. The PGA segment dominated the market with a revenue share of around 34.6% in 2023.
 

  • PGA sutures are absorbable, meaning they gradually break down and are absorbed by the body. This eliminates the need for suture removal, reducing the risk of infection and improving patient comfort.
     
  • Moreover, PGA sutures provide excellent initial tensile strength, which is essential for maintaining tissue approximation during the critical early stages of wound healing. This strength supports the delicate eye tissues and ensures proper wound closure. These features contribute to their segmental growth.
     

By coating, the ophthalmic sutures industry is categorized into coated and uncoated. The uncoated segment is anticipated to dominate the market with a revenue of around USD 1.1 billion in 2032.
 

  • Uncoated sutures tend to have a higher friction coefficient compared to coated sutures, which enhances their knot security. This is particularly important in ophthalmic surgeries where secure knots are critical for maintaining tissue approximation and preventing slippage.
     
  • Moreover, uncoated sutures do not have additional substances that might provoke an inflammatory response. In ophthalmic surgeries, where the eye's delicate tissues are involved, minimizing inflammation is crucial for optimal healing and patient outcomes.
     

By material structures, the ophthalmic sutures market is categorized into monofilament and multifilament/braided. The monofilament segment is anticipated to dominate the market with the fastest growth rate of CAGR 6.4% till 2032.
 

  • The smooth surface of monofilament sutures minimizes tissue drag and reduces the inflammatory response. This is particularly important in the delicate tissues of the eye, where inflammation can significantly impact healing and visual outcomes.
     
  • Moreover, monofilament sutures glide more easily through tissue, causing less trauma and reducing the likelihood of tissue damage. This ease of passage is beneficial in ophthalmic procedures that require precision and delicacy, hence increasing its demand in the market.
     

By absorption, the market is categorized into absorbable and non-absorbable. The non-absorbable segment dominated the market with a revenue share of around 83.2% in 2023.
 

  • Non-absorbable sutures provide long-term stability and strength, which is crucial for ophthalmic procedures where the sutures need to maintain their integrity over an extended period.
     
  • Additionally, non-absorbable sutures offer consistent performance and predictable behavior, which are critical for the precise and delicate nature of ophthalmic surgeries. This consistency ensures reliable outcomes.
     

By application, the ophthalmic sutures market is categorized into cataract surgery, corneal transplantation surgery, glaucoma surgery, vitrectomy, oculoplastic surgery, and other applications. The cataract surgery segment is anticipated to dominate the market with a revenue of around USD 772.6 million in 2032.
 

  • Cataracts are a common age-related condition, and the global aging population contributes significantly to the high prevalence of cataracts. This leads to an increased number of cataract surgeries.
     
  • Moreover, advances in surgical techniques and technologies have made cataract surgeries more efficient and widely accessible, contributing to the higher volume of procedures.
     
Ophthalmic Sutures Market, By End Use (2023)

By end use, the market is categorized into hospitals, ambulatory surgical centers, and other end users. The hospital segment dominated the market with a revenue share of around 57.5% in 2023.
 

  • Hospitals typically have advanced surgical facilities and state-of-the-art equipment necessary for performing complex ophthalmic surgeries. This makes them a preferred choice for both patients and surgeons.
     
  • Additionally, hospitals are better equipped to handle emergencies and unexpected complications during surgeries, providing a safer environment for patients undergoing intricate ophthalmic procedures. Hence contributes to segmental growth.
     
North America Ophthalmic Sutures Market, 2021 – 2032 (USD Million)

North America ophthalmic sutures market accounted for USD 353.5 million in revenue in 2023 and is predicted to witness substantial market growth over the analysis timeline.
 

  • The aging population in North America, particularly in the U.S. and Canada, is leading to an increase in age-related eye conditions such as cataracts, glaucoma, and age-related macular degeneration (AMD). This demographic trend drives the demand for ophthalmic surgeries, thereby offering a lucrative opportunity for growth of the market.  
     
  • Additionally, North America boasts advanced healthcare facilities and well-equipped hospitals and clinics that can perform complex ophthalmic surgeries. The availability of these facilities supports the high volume of ophthalmic procedures.
     

The U.S. ophthalmic sutures industry is anticipated to reach USD 543.6 million by 2032.
 

  • Comprehensive health insurance coverage in the U.S. ensures that a large portion of the population has access to ophthalmic surgeries and related treatments, including the use of ophthalmic sutures.
     
  • Furthermore, increasing awareness about the importance of regular eye examinations and preventive eye care contributes to early diagnosis and treatment of eye conditions. This trend leads to more frequent use of ophthalmic sutures in surgical procedures aimed at preserving vision.
     

The ophthalmic sutures market in UK is expected to experience significant and promising growth from 2024 to 2032.
 

  • The UK maintains stringent regulatory standards for medical devices or ophthalmic devices, including ophthalmic sutures, ensuring their safety, efficacy, and quality. Compliance with these standards fosters confidence in the use of ophthalmic sutures among healthcare providers and patients.
     
  • Additionally, government funding and support for research in ophthalmology and related fields promote advancements in surgical techniques and materials, benefiting the market.
     

Japan ophthalmic sutures market is anticipated to witness lucrative growth between 2024 – 2032.
 

  • Cataract surgery is one of the most common ophthalmic procedures performed in Japan, with millions of surgeries conducted annually. Each surgery typically requires the use of ophthalmic sutures, contributing significantly to market demand.
     
  • Furthermore, Japan allocates substantial healthcare expenditure towards eye care services, reflecting the importance placed on maintaining vision health and treating eye diseases.
Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

The global market size for ophthalmic sutures was valued at approximately USD 906.3 million in 2023 and is expected to reach around USD 1.6 billion by 2032, driven by a CAGR of 6.2% from 2024 to 2032.

Synthetic sutures accounted for USD 620.5 million in revenue in 2023, due to their superior tensile strength, elasticity, and biocompatibility.

The North America market generated USD 353.5 million in 2023, driven by the aging population and increasing incidence of age-related eye conditions.

Major players in the industry include Alcon, Assut Medical, Aurolab, Accutome, B Braun Melsungen AG, Corzamedical, DemeTECH Corporation, Ethicon (J&J), FCI Ophthalmics, Geuder, Mani, Medtronic, Teleflex Incorporated, and Unilene.

Ophthalmic Sutures Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 14
  • Tables & Figures: 219
  • Countries covered: 18
  • Pages: 130
 Download Free Sample